Microsomal enzyme induction

Microsomal enzyme induction

• 1.
  Microsomal Enzymes Dr. RenuYadav Resident Pharmacology
• 2.
  Learning Objectives • Introduction •Biotransformation • Microsomal enzymes • Cytochrome p450 enzymes • Clinical relevance of drug metabolism • Conclusion
• 3.
  Bio-transformation • DEFINITION :Chemical alteration of the drug in the body. Non-polar compounds to polar (lipid-insoluble) compounds. • SITES : liver kidney intestine lungs
• 4.
  • ACTIONS 1. Inactivation EG: Ibuprofen, lidocaine, propranolol 2. Active metabolite from active drug Active drug Active metabolite Morphine Morphine-6-glucoronide Codeine Morphine Amitryptiline Nortriptiline Spironolactone Canrenone Imipramine Desimipramine
• 5.
  3. Active metabolitefrom inactive drug Prodrug Active form Levodopa Dopamine Enalapril Enalaprilat Prednisone Prednisolone Sulfasalazine 5-aminosalicylic acid Acyclovir Acyclovir triphosphate
• 6.
  Bio-transformation Phases Phase 1Phase 2 • Non-Synthetic/functionalization reactions • Metabolite may be active or inactive 1. Oxidation 2. Reduction 3. Hydrolysis 4. Cyclization 5. De-cyclization (On Race Honda CD) • Synthetic / conjugation reaction • Mostly inactive 1. Glucuronide conjugation 2. Acetylation 3. Methylation 4. Sulphate conjugation 5. Glycine conjugation 6. Glutathione conjugation 7. Ribonucleotide/nucleotide synthesis (Get A Motor Scooter, Go Get Racing)
• 8.
  ENZYME INDUCTION Microsomal Non-microsomal Smoothendoplasmic reticulum( in liver, kidney, intestine, lungs) Cytoplasm and m itochondria (in liver) Eg : Monooxygenases, CYP450, UGT, epoxide hydrolases etc. Esterases, amidases, some flavoprotein, most conjugases Catalyzes oxidation, reduction, glucoronide conjugation etc. All conjugation except glucoronidation Inducible Non-inducible
• 9.
  Microsomal Enzymes • Microsomes: ER is isolated by homogenization and fractionation of cells reform into Vesicles known as microsomes
• 10.
  • They areinducible by drugs and environmental factors and some dietary constituents. • For e,g 1. A component of grapefruit juice inhibits drug metabolism (leading to potentially disastrous consequences, including cardiac dysrhythmias) 2. Brussel sprouts and cigarette smoke induce P450 enzymes. 3. Components of the herbal medicine St John’s wort induces CYP450 isoenzymes as well as P-glycoprotein (P-gp)
• 11.
  Different Microsomal Enzymes •Flavin monooxygenases • Cytochrome p450 • UDP glucoronosyl transferases • Glutathione s transferases • Epoxide hydrolases • Carboxyl esterases
• 12.
  Cytochrome P450 • CytochromeP450 enzymes are heme proteins, comprising a large family (‘superfamily’) each referred to as CYP followed by a defining set of numbers and a letter. • P450 because reduced heme protein binds with CO to form a complex that absorbs light maximally at 450nm. • Not all 57 human CYPs are involved in drug metabolism. • CYP enzymes in families 1–3 mediate 70%–80% of all drug metabolism. • Twelve CYPs accounted for 93.0% of drug metabolism.
• 13.
  Nomenclature
• 14.
  • CYP Isoformsfound in liver are CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C18, CYP2C19, CYP2D6, CYP2E1 CYP3A4, CYP3A5 CYP4A11 CYP7 • The most active CYPs for drug metabolism are of CYP2c, CYP2d, and CYP3a subfamilies.
• 16.
  Cytochrome P450 Inducers •Carbamazepines • Rifampicin • Alcohol • Phenytoin • Griseofulvin • Phenobarbitone • Sulphonylureas (CRAP GPS)
• 17.
  Enzyme Induction Enzyme induction Substratemetabolism Non active metabolite or Reactive metabolite Pharmacological action Pharmacological action/ toxic effects
• 18.
  Drug interaction dueto enzyme induction Auto-induction : Because the inducing agent is often itself a substrate for the induced enzymes, the process can result in slowly developing tolerance Eg: carbamazepine, rifampicin, nevirapine dose needed to be doubled after 2 weeks. Enzyme induction can increase toxicity of an active metabolite of paracetamol by its metabolite N-acetyl-P-benzoquinone imine (NAPQI). The risk of serious hepatic injury following paracetamol overdose is increased in patients in whom CYP has been induced, for example, by chronic alcohol Consumption. Antibiotic rifampicin, given for 3 days, reduces the effectiveness of warfarin as an anticoagulant.
• 19.
  Effect of rifampicinon the metabolism and anticoagulant action of warfarin.
• 20.
  Therapeutic Uses OfEnzyme Induction • Non-hemolytic anemia : Its due to deficient glucuronidation of bilirubin, phenobarbitone hastens its clearance. • Cushings syndrome: Phenytoin may reduce the manifestation by enhancing degradation of adrenal steroids. • Chronic poisoning • Liver diseases.
• 21.
  Enzyme Inhibition • Competitiveinhibition of co-administered drug : Cimetidine , Ketoconazole, Erythromycin • Suicidal inhibition : Chloramphenicol Clopidogrel Ritonavir
• 22.
  Cytochrome P450 Inhibitors •Sodium valproate Chloramphenicol • Isoniazid Erythromycin • Cimetidine Sulfonamides • Ketoconazole Ciprofloxacin • Fluconazole Omeprazole • Alcohol & grapefruit juice Metronidazole (SICKFACES.COM)
• 23.
  Drug Interaction DueTo Enzyme Inhibition • Several inhibitors of drug metabolism influence the metabolism of different stereoisomers selectively. • Examples of drugs that inhibit the metabolism of the active (S) and less active (R) isomers of warfarin Inhibition of metabolism drugs Stereoselective for ( S ) isomer Phenylbutazone Metronidazole Sulfinpyrazone Trimethoprim– sulfamethoxazole Disulfiram Stereoselective for ( R ) isomer Cimetidine Omeprazole Non-stereoselective amiodarone
• 24.
  CYP 3A4 SUBSTRATE INDUCERSINHIBITORS Acetaminophen Buspirone Cisapride Diazepam Ethinyl Estradiol Erythromycin Felodipine Statins Terbinafine Sildenafil (ABCDEF Short Too Sweet) Carbamazepine Rifampicin Phenytoin Phenobarbitone Efavirenz Glucocorticoids St. Johns Wart (Chronic Routine PEGS) Grapefruit Juice Cimetidine Azoles Macrolide Protease Inhibitor (Go CAMP)
• 25.
  UDP Glucoronosyl Transferases(UGT) •Catalyse phase II reaction - Glucuronidation • Glucoronides excreted via – Intestine via bile (majority) Kidney (minority) • Glucoronides are cleaved by beta-glucuronidase found in bacteria of lower GIT – enterohepatic circulation of drugs eg. OCPs • UGT 1 – drugs metabolism UGT 2 – endogenous substrate metabolism
• 26.
  Flavin Monooxygenases • PhaseI reaction • 6 families are present • FMO 3 is most abundant in human liver • They are not induced or inhibited by any drug Not involved in drug-drug interaction
• 27.
  Epoxide Hydrolases • Carryout hydrolysis of epoxide, many of which are produced by CYP • It metabolises very few drugs eg. Carbamazepine
• 28.
  Glutathione S Transferases(GST) • Found in both ER and cytosol • Microsomal form – metabolism of endogenous leukotrienes and prostaglandins • Cytosolic form – conjugation, reduction, isomerization reaction of drug metabolism.
• 29.
  Factors Affecting DrugMetabolism Genetic Factors Non-genetic Factors Genetic polymorphism Commensal Gut Microflora Diet And Envt Factors Age And Sex Concurrent Exposure To Inhibitors or Inducers Diseases
• 30.
  Genetic Polymorphism • Definition: Occurrence of a variant allele of a gene at a population frequency more than 1%, resulting in altered expression of functional activity of the gene product, or both. • Based on metabolic ratio, individuals are divided into 1- Poor metabolisers 2- Extensive metabolisers 3- Ultra rapid metabolisers • Metabolic Ratio = Percentage of dose excreted as unchanged drug Percent of dose excreted as metabolite in urine
• 31.
  Conclusion • Understanding drugmetabolism and interaction within the body allows principles of biotransformation to be applied in better designing and therapeutic uses of drug. • Increased understanding of biotransformation based on pharmacogenomics will also render pharmacologic treatment of disease more individualised, efficacious and safe.
• 32.
  THANK YOU